Featured
2 days ago
CEO Spotlight: Acurx Pharmaceuticals CEO Is Confident His Ibezapolstat Can Earn Front-Line Designation To Treat C. difficile ($ACXP)
Acurx Pharmaceuticals’ (NASDAQ: ACXP) mission in bringing to market an effective and durable treatment for…
Featured
4 weeks ago
KwikClick, Inc. Is Disrupting The E-commerce Ecosystem ($KWIK)
Total annual retail e-commerce sales in the US are slated to surpass the $1 trillion…
Featured
November 30, 2022
First Wave BioPharma Stock In Play After Filing IND To Accelerate Bringing Enhanced Adrulipase To Market ($FWBI)
First Wave BioPharma (NASDAQ: FWBI) reached a milestone that could quickly become a catalyst. And…
Featured
October 31, 2022
Yes, KWIK Really Does Have A Game-Changing Platform Accretive To The Trillion Dollar E-Commerce Landscape…Here’s Proof ($KWIK)
Most investors have heard the term “game changer” when describing a company offering innovative products…
Featured
October 26, 2022
FatBrain AI Keeps Getting Bigger, Creating A Value Proposition Too Big To Ignore ($LZGI)
FatBrain AI (OTCQB: LZGI) is getting bigger. And it’s happening fast. Following a recent announcement…
Featured
October 18, 2022
Kaival Brands’ Stock Is Soaring 60% In October As BIDI®Stick Phamacokinetics Supports U.S. Marketing Approvals ($KAVL)
Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) stock is higher by over 60% since the…
